Top News

Dec 01, 2016
The House-approved 21st Century Cures legislation supports initiatives for medical research, drug development, and faster approvals, but comes up short on actual appropriations.
Nov 09, 2016
What’s ahead for the healthcare and pharmaceutical industries?
Oct 27, 2016
By BioPharm International Editors
Teva and IBM expanded their partnership to focus on drug development and chronic disease management.
Oct 24, 2016
FDA’s new Office of Tissues and Advanced Therapies will oversee a growing range of cellular and genetic products.
Oct 06, 2016
By BioPharm International Editors
The companies are collaborating on the commercialization of two biosimilar candidates in the US and Canada.
Sep 26, 2016
By BioPharm International Editors
Pfizer announced its decision to remain one company after debating the possibility of splitting Pfizer Innovative Health and Pfizer Essential Health into two, separate publicly traded companies.
Sep 20, 2016
By BioPharm International Editors
Walmsley will succeed Andrew Witty as CEO of the British drug maker.
Sep 07, 2016
By BioPharm International Editors
The department gave Moderna $8.2 million to accelerate development of an mRNA-based Zika vaccine.
Aug 26, 2016
By BioPharm International Editors
The initiative targets countries with less developed and evolving healthcare systems such as Latin America, South East Asia, and Africa.
Aug 22, 2016
By BioPharm International Editors
Pfizer will acquire Medivation for approximately $14 billion.
native1_300x100
lorem ipsum